Terazosin HCl en es it fr

Terazosin HCl Brand names, Terazosin HCl Analogs

Terazosin HCl Brand Names Mixture

  • No information avaliable

Terazosin HCl Chemical_Formula

C19H25N5O4

Terazosin HCl RX_link

http://www.rxlist.com/cgi/generic/teraz.htm

Terazosin HCl fda sheet

Terazosin_HCl FDA

Terazosin HCl msds (material safety sheet)

Terazosin HCl Synthesis Reference

M. Winn et al., U.S. Pat. 4,026,894 (1977)

Terazosin HCl Molecular Weight

387.433 g/mol

Terazosin HCl Melting Point

273 oC

Terazosin HCl H2O Solubility

29.7mg/mL

Terazosin HCl State

Solid

Terazosin HCl LogP

0.875

Terazosin HCl Dosage Forms

Tablet

Terazosin HCl Indication

For the treatment of symptomatic benign prostatic hyperplasia (BPH) and also for hypertension.

Terazosin HCl Pharmacology

Terazosin, classified as a quinazoline, is similar to doxazosin and prazosin. As an alpha-adrenergic blocking agent, terazosin is used to treat hypertension and benign prostatic hypertrophy (BPH). Terazosin produces vasodilation and reduces peripheral resistance but in general has slight effect on cardiac output. Antihypertensive effect with chronic dosing is usually not accompanied by reflex tachycardia.

Terazosin HCl Absorption

Essentially completely absorbed in man (90% bioavailability).

Terazosin HCl side effects and Toxicity

LD50=259.3mg/kg (i.v. in mice)

Terazosin HCl Patient Information

Terazosin HCl Organisms Affected

Humans and other mammals